Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Differential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response.
MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study.
Heterogeneous induction of microglia M2a phenotype by central administration of interleukin-4.
Altered transition metal homeostasis in the cuprizone model of demyelination.
Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: special focus on helminth-derived treatments.
Gait variability in people with neurological disorders: A systematic review and meta-analysis.
Oxidative stress and antioxidants in neurological diseases: is there still hope?
Multiple sclerosis in India: An overview.
The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.
Factors Associated with Employment Status in Individuals with Multiple Sclerosis.
The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells.
B cell-directed therapies in multiple sclerosis.
IL-27-induced modulation of autoimmunity and its therapeutic potential.
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
Progressive MS: from pathophysiology to drug discovery.
Sequencing the immunopathologic heterogeneity in multiple sclerosis.
Impact of Notch1 Deletion in Macrophages on Proinflammatory Cytokine Production and the Outcome of Experimental Autoimmune Encephalomyelitis.
miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4(+) T lymphocytes of patients with relapsing-remitting multiple sclerosis.
Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.
Quantitative analysis of hindlimbs locomotion kinematics in spinalized rats treated with Tamoxifen plus treadmill exercise.
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
[The clinical outcomes of idiopathic optic neuritis with no light perception in 21 eyes].
If I had clinically isolated syndrome with magnetic resonance imaging diagnostic of multiple sclerosis, I would take vitamin D 10,000 IU daily: Yes.
Progress in multiple sclerosis genetics.
Rituximab for tumefactive demyelination refractory to corticosteroids and plasma exchange.

Pages